BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res. 2012;31:38. [PMID: 22546315 DOI: 10.1186/1756-9966-31-38] [Cited by in Crossref: 126] [Cited by in F6Publishing: 118] [Article Influence: 12.6] [Reference Citation Analysis]
Number Citing Articles
1 Dhahbi JM. Circulating small noncoding RNAs as biomarkers of aging. Ageing Res Rev 2014;17:86-98. [PMID: 24607831 DOI: 10.1016/j.arr.2014.02.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
2 Qu Z, Wu J, Wu J, Luo D, Jiang C, Ding Y. Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro. J Exp Clin Cancer Res. 2016;35:159. [PMID: 27716356 DOI: 10.1186/s13046-016-0430-z] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 13.0] [Reference Citation Analysis]
3 Sapre N, Selth LA. Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play. Prostate Cancer 2013;2013:539680. [PMID: 23577261 DOI: 10.1155/2013/539680] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
4 Cuppen BV, Rossato M, Fritsch-Stork RD, Concepcion AN, Schenk Y, Bijlsma JW, Radstake TR, Lafeber FP; all SRU investigators. Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis? Arthritis Res Ther. 2016;18:189. [PMID: 27558398 DOI: 10.1186/s13075-016-1085-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
5 Fang Z, Tang J, Bai Y, Lin H, You H, Jin H, Lin L, You P, Li J, Dai Z, Liang X, Su Y, Hu Q, Wang F, Zhang ZY. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma. J Exp Clin Cancer Res 2015;34:86. [PMID: 26297223 DOI: 10.1186/s13046-015-0198-6] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 11.1] [Reference Citation Analysis]
6 Shen W, Song M, Liu J, Qiu G, Li T, Hu Y, Liu H. MiR-26a promotes ovarian cancer proliferation and tumorigenesis. PLoS One 2014;9:e86871. [PMID: 24466274 DOI: 10.1371/journal.pone.0086871] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
7 Li H, Zhang K, Liu LH, Ouyang Y, Guo HB, Zhang H, Bu J, Xiao T. MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncol Lett 2015;10:1662-8. [PMID: 26622728 DOI: 10.3892/ol.2015.3378] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
8 Huang YH, Liang KH, Chien RN, Hu TH, Lin KH, Hsu CW, Lin CL, Pan TL, Ke PY, Yeh CT. A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic Patients. Sci Rep. 2017;7:523. [PMID: 28364124 DOI: 10.1038/s41598-017-00631-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
9 Kövesdi A, Kurucz PA, Nyírő G, Darvasi O, Patócs A, Butz H. Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors. Cancers (Basel) 2020;12:E2488. [PMID: 32887459 DOI: 10.3390/cancers12092488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li JR, Tong CY, Sung TJ, Kang TY, Zhou XJ, Liu CC. CMEP: a database for circulating microRNA expression profiling. Bioinformatics 2019;35:3127-32. [PMID: 30668638 DOI: 10.1093/bioinformatics/btz042] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Kishikawa T, Otsuka M, Ohno M, Yoshikawa T, Takata A, Koike K. Circulating RNAs as new biomarkers for detecting pancreatic cancer. World J Gastroenterol 2015; 21(28): 8527-8540 [PMID: 26229396 DOI: 10.3748/wjg.v21.i28.8527] [Cited by in CrossRef: 92] [Cited by in F6Publishing: 89] [Article Influence: 13.1] [Reference Citation Analysis]
12 Ferhan AR, Jackman JA, Park JH, Cho NJ, Kim DH. Nanoplasmonic sensors for detecting circulating cancer biomarkers. Adv Drug Deliv Rev 2018;125:48-77. [PMID: 29247763 DOI: 10.1016/j.addr.2017.12.004] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 16.0] [Reference Citation Analysis]
13 Liu Y, Li Z, Wu L, Wang Z, Wang X, Yu Y, Zhao Q, Luo F. MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma. Cancer Cell Int 2014;14:24. [PMID: 24602316 DOI: 10.1186/1475-2867-14-24] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
14 Zawadzka M, Jagodziński PP. Exercise-induced epigenetic regulations in inflammatory related cells. J Appl Biomed 2017;15:63-70. [DOI: 10.1016/j.jab.2016.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Zhang P, Ouyang Y, Sohn YS, Fadeev M, Karmi O, Nechushtai R, Stein I, Pikarsky E, Willner I. miRNA-Guided Imaging and Photodynamic Therapy Treatment of Cancer Cells Using Zn(II)-Protoporphyrin IX-Loaded Metal-Organic Framework Nanoparticles. ACS Nano 2022;16:1791-801. [PMID: 35020370 DOI: 10.1021/acsnano.1c04681] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ventriglia G, Nigi L, Sebastiani G, Dotta F. MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes. Biomed Res Int 2015;2015:749734. [PMID: 26339637 DOI: 10.1155/2015/749734] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
17 Shi J, Bao X, Liu Z, Zhang Z, Chen W, Xu Q. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma. Theranostics 2019;9:920-31. [PMID: 30867806 DOI: 10.7150/thno.30339] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
18 Zhao H, Shen J, Hodges TR, Song R, Fuller GN, Heimberger AB. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Mol Cancer 2017;16:59. [PMID: 28284220 DOI: 10.1186/s12943-017-0628-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
19 Zhang YC, Xu Z, Zhang TF, Wang YL. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma. World J Gastroenterol 2015; 21(34): 9853-9862 [PMID: 26379392 DOI: 10.3748/wjg.v21.i34.9853] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
20 Jin Z, Geißler D, Qiu X, Wegner KD, Hildebrandt N. A Rapid, Amplification-Free, and Sensitive Diagnostic Assay for Single-Step Multiplexed Fluorescence Detection of MicroRNA. Angew Chem Int Ed Engl 2015;54:10024-9. [PMID: 26226913 DOI: 10.1002/anie.201504887] [Cited by in Crossref: 136] [Cited by in F6Publishing: 131] [Article Influence: 19.4] [Reference Citation Analysis]
21 Kotb S, Mosharafa A, Essawi M, Hassan H, Meshref A, Morsy A. Circulating miRNAs 21 and 221 as biomarkers for early diagnosis of prostate cancer. Tumor Biol 2014;35:12613-7. [DOI: 10.1007/s13277-014-2584-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
22 Xu C, Zhang H, Zhou W, Wu H, Shen X, Chen Y, Liao M, Liu Y, Yuan W. MicroRNA-10a, -210, and -563 as circulating biomarkers for ossification of the posterior longitudinal ligament. The Spine Journal 2019;19:735-43. [DOI: 10.1016/j.spinee.2018.10.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
23 Sohn W, Kim J, Kang SH, Yang SR, Cho JY, Cho HC, Shim SG, Paik YH. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma. Exp Mol Med. 2015;47:e184. [PMID: 26380927 DOI: 10.1038/emm.2015.68] [Cited by in Crossref: 205] [Cited by in F6Publishing: 211] [Article Influence: 29.3] [Reference Citation Analysis]
24 Fang F, Li Z, Yu J, Long Y, Zhao Q, Ding X, Wu L, Shao S, Zhang L, Xiang W. MicroRNAs secreted by human embryos could be potential biomarkers for clinical outcomes of assisted reproductive technology. J Adv Res 2021;31:25-34. [PMID: 34194830 DOI: 10.1016/j.jare.2021.01.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Bill KL, Casadei L, Prudner BC, Iwenofu H, Strohecker AM, Pollock RE. Liposarcoma: molecular targets and therapeutic implications. Cell Mol Life Sci 2016;73:3711-8. [PMID: 27173057 DOI: 10.1007/s00018-016-2266-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
26 Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M. Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia. Clin Transl Gastroenterol 2019;10:e00029. [PMID: 31009404 DOI: 10.14309/ctg.0000000000000029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
27 Du M, Liu S, Gu D, Wang Q, Zhu L, Kang M, Shi D, Chu H, Tong N, Chen J, Adams TS, Zhang Z, Wang M. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients. Carcinogenesis 2014;35:2723-30. [PMID: 25239640 DOI: 10.1093/carcin/bgu189] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
28 Wright K, Plain K, Purdie A, Saunders BM, de Silva K. Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals. Infect Immun 2019;88:e00401-19. [PMID: 31527123 DOI: 10.1128/IAI.00401-19] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
29 Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016 [PMID: 34616508 DOI: 10.4251/wjgo.v13.i9.995] [Reference Citation Analysis]
30 Bahmanpour Z, Sheervalilou R, Choupani J, Shekari Khaniani M, Montazeri V, Mansoori Derakhshan S. A new insight on serum microRNA expression as novel biomarkers in breast cancer patients. J Cell Physiol 2019;234:19199-211. [PMID: 31026062 DOI: 10.1002/jcp.28656] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
31 Chen L, Yang J, Lü J, Cao S, Zhao Q, Yu Z. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples. Brain Behav 2018;8:e00941. [PMID: 29670823 DOI: 10.1002/brb3.941] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
32 Jiang B, Mu W, Wang J, Lu J, Jiang S, Li L, Xu H, Tian H. MicroRNA-138 functions as a tumor suppressor in osteosarcoma by targeting differentiated embryonic chondrocyte gene 2. J Exp Clin Cancer Res. 2016;35:69. [PMID: 27095063 DOI: 10.1186/s13046-016-0348-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
33 Zhou Z, Sohn YS, Nechushtai R, Willner I. DNA Tetrahedra Modules as Versatile Optical Sensing Platforms for Multiplexed Analysis of miRNAs, Endonucleases, and Aptamer-Ligand Complexes. ACS Nano 2020;14:9021-31. [PMID: 32539340 DOI: 10.1021/acsnano.0c04031] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 24.0] [Reference Citation Analysis]
34 Song T, Liang Y, Cao Z, Du W, Li Y. Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection. Biomed Res Int 2017;2017:4680650. [PMID: 28357401 DOI: 10.1155/2017/4680650] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Zhang L, Shan X, Wang J, Zhu J, Huang Z, Zhang H, Zhou X, Cheng W, Shu Y, Zhu W, Liu P. A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients. Oncotarget 2017;8:86897-907. [PMID: 29156844 DOI: 10.18632/oncotarget.19666] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
36 Kumar S, Vijayan M, Bhatti JS, Reddy PH. MicroRNAs as Peripheral Biomarkers in Aging and Age-Related Diseases. Prog Mol Biol Transl Sci 2017;146:47-94. [PMID: 28253991 DOI: 10.1016/bs.pmbts.2016.12.013] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 17.0] [Reference Citation Analysis]
37 Haldrup C, Kosaka N, Ochiya T, Borre M, Høyer S, Orntoft TF, Sorensen KD. Profiling of circulating microRNAs for prostate cancer biomarker discovery. Drug Deliv and Transl Res 2014;4:19-30. [DOI: 10.1007/s13346-013-0169-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
38 Niu J, Sun Y, Guo Q, Niu D, Liu B. Serum miR-95-3p is a diagnostic and prognostic marker for osteosarcoma. Springerplus 2016;5:1947. [PMID: 27917340 DOI: 10.1186/s40064-016-3640-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
39 Godfrey AC, Xu Z, Weinberg CR, Getts RC, Wade PA, Deroo LA, Sandler DP, Taylor JA. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res. 2013;15:R42. [PMID: 23705859 DOI: 10.1186/bcr3428] [Cited by in Crossref: 73] [Cited by in F6Publishing: 72] [Article Influence: 8.1] [Reference Citation Analysis]
40 Shen J, Hu Q, Schrauder M, Yan L, Wang D, Medico L, Guo Y, Yao S, Zhu Q, Liu B, Qin M, Beckmann MW, Fasching PA, Strick R, Johnson CS, Ambrosone CB, Zhao H, Liu S. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection. Oncotarget 2014;5:5284-94. [PMID: 25051376 DOI: 10.18632/oncotarget.2014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
41 Zhang W, Zhang T, Jin R, Zhao H, Hu J, Feng B, Zang L, Zheng M, Wang M. MicroRNA-301a promotes migration and invasion by targeting TGFBR2 in human colorectal cancer. J Exp Clin Cancer Res. 2014;33:113. [PMID: 25551793 DOI: 10.1186/s13046-014-0113-6] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 4.6] [Reference Citation Analysis]
42 Nagy ZB, Barták BK, Kalmár A, Galamb O, Wichmann B, Dank M, Igaz P, Tulassay Z, Molnár B. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression. Pathol Oncol Res 2019;25:97-105. [PMID: 28980150 DOI: 10.1007/s12253-017-0308-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
43 Zhao H, Shen J, Hu Q, Davis W, Medico L, Wang D, Yan L, Guo Y, Liu B, Qin M, Nesline M, Zhu Q, Yao S, Ambrosone CB, Liu S. Effects of preanalytic variables on circulating microRNAs in whole blood. Cancer Epidemiol Biomarkers Prev 2014;23:2643-8. [PMID: 25472672 DOI: 10.1158/1055-9965.EPI-14-0550] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
44 D'Angelo E, Fassan M, Maretto I, Pucciarelli S, Zanon C, Digito M, Rugge M, Nitti D, Agostini M. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma. Oncotarget 2016;7:28647-57. [PMID: 27081702 DOI: 10.18632/oncotarget.8725] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 7.8] [Reference Citation Analysis]
45 Kumar S, Reddy PH. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease? Biochim Biophys Acta 2016;1862:1617-27. [PMID: 27264337 DOI: 10.1016/j.bbadis.2016.06.001] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 18.5] [Reference Citation Analysis]
46 Papadaki C, Thomopoulou K, Monastirioti A, Koronakis G, Papadaki MA, Rounis K, Vamvakas L, Nikolaou C, Mavroudis D, Agelaki S. MicroRNAs Regulating Tumor and Immune Cell Interactions in the Prediction of Relapse in Early Stage Breast Cancer. Biomedicines 2021;9:421. [PMID: 33924670 DOI: 10.3390/biomedicines9040421] [Reference Citation Analysis]
47 Yeong J, Thike AA, Tan PH, Iqbal J. Identifying progression predictors of breast ductal carcinoma in situ. J Clin Pathol 2017;70:102-8. [PMID: 27864452 DOI: 10.1136/jclinpath-2016-204154] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
48 Chen Y, He J, Su C, Wang H, Chen Y, Guo W, Li Y, Ding G. LINC00461 affects the survival of patients with renal cell carcinoma by acting as a competing endogenous RNA for microRNA‑942. Oncol Rep 2019;42:1924-34. [PMID: 31545458 DOI: 10.3892/or.2019.7311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Qin Q, Furong W, Baosheng L. Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res 2014;33:50. [PMID: 24909053 DOI: 10.1186/1756-9966-33-50] [Cited by in Crossref: 100] [Cited by in F6Publishing: 96] [Article Influence: 12.5] [Reference Citation Analysis]
50 Igaz I, Igaz P. Tumor surveillance by circulating microRNAs: a hypothesis. Cell Mol Life Sci 2014;71:4081-7. [PMID: 25037157 DOI: 10.1007/s00018-014-1682-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
51 Zhu Z, Xu Y, Du J, Tan J, Jiao H. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival. J Surg Oncol 2014;109:89-94. [PMID: 24166773 DOI: 10.1002/jso.23475] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
52 Liu X, Luo Y, Luo Z, Yang H. Biomarker Studies in Multiple Sclerosis: From Proteins to Noncoding RNAs. Neurochem Res 2014;39:1661-74. [DOI: 10.1007/s11064-014-1386-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
53 Liang L, Nong L, Zhang S, Zhao J, Ti H, Dong Y, Zhang B, Li T. The downregulation of PRDM1/Blimp-1 is associated with aberrant expression of miR-223 in extranodal NK/T-cell lymphoma, nasal type. J Exp Clin Cancer Res 2014;33:7. [PMID: 24438193 DOI: 10.1186/1756-9966-33-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
54 Dhahbi JM, Atamna H, Li R, Yamakawa A, Guerrero N, Lam HT, Mote P, Spindler SR. MicroRNAs Circulate in the Hemolymph of Drosophila and Accumulate Relative to Tissue microRNAs in an Age-Dependent Manner. Genomics Insights 2016;9:29-39. [PMID: 27042094 DOI: 10.4137/GEI.S38147] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
55 Xiang J, Bian C, Wang H, Huang S, Wu D. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer. J Exp Clin Cancer Res 2015;34:8. [PMID: 25636908 DOI: 10.1186/s13046-015-0125-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
56 Sinkovics JG. The cnidarian origin of the proto-oncogenes NF-κB/STAT and WNT-like oncogenic pathway drives the ctenophores (Review). Int J Oncol 2015;47:1211-29. [PMID: 26239915 DOI: 10.3892/ijo.2015.3102] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
57 Zhang X, Li C, Liu X, Lu C, Bai C, Zhao Z, Sun B. Differential expression of miR-499 and validation of predicted target genes in the testicular tissue of swine at different developmental stages. DNA Cell Biol 2015;34:464-9. [PMID: 25786081 DOI: 10.1089/dna.2014.2728] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
58 Liu CG, Wang JL, Li L, Xue LX, Zhang YQ, Wang PC. MicroRNA-135a and -200b, potential Biomarkers for Alzheimer׳s disease, regulate β secretase and amyloid precursor protein. Brain Res 2014;1583:55-64. [PMID: 25152461 DOI: 10.1016/j.brainres.2014.04.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 6.9] [Reference Citation Analysis]
59 Falcone G, Felsani A, D'Agnano I. Signaling by exosomal microRNAs in cancer. J Exp Clin Cancer Res 2015;34:32. [PMID: 25886763 DOI: 10.1186/s13046-015-0148-3] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 13.7] [Reference Citation Analysis]
60 Wang Z, Lu Y, Zhang X, Ren X, Wang Y, Li Z, Xu C, Han J. Serum microRNA is a promising biomarker for osteogenesis imperfecta. Intractable Rare Dis Res 2012;1:81-5. [PMID: 25343076 DOI: 10.5582/irdr.2012.v1.2.81] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
61 Tavallaie R, De Almeida SRM, Gooding JJ. Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes: Toward biosensors for the detection of circulating microRNA. WIREs Nanomed Nanobiotechnol 2015;7:580-92. [DOI: 10.1002/wnan.1324] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
62 Marchesi F, Regazzo G, Palombi F, Terrenato I, Sacconi A, Spagnuolo M, Donzelli S, Marino M, Ercolani C, Di Benedetto A, Blandino G, Ciliberto G, Mengarelli A, Rizzo MG. Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot study. J Exp Clin Cancer Res 2018;37:95. [PMID: 29716630 DOI: 10.1186/s13046-018-0768-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
63 Zhu D, Miao ZY, Hu Y, Zhang XJ. Single-step, homogeneous and sensitive detection for microRNAs with dual-recognition steps based on luminescence resonance energy transfer (LRET) using upconversion nanoparticles. Biosens Bioelectron 2018;100:475-81. [PMID: 28963965 DOI: 10.1016/j.bios.2017.09.039] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
64 Pallante P, Battista S, Pierantoni GM, Fusco A. Deregulation of microRNA expression in thyroid neoplasias. Nat Rev Endocrinol 2014;10:88-101. [PMID: 24247220 DOI: 10.1038/nrendo.2013.223] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 7.8] [Reference Citation Analysis]
65 Liu X, Luo HN, Tian WD, Lu J, Li G, Wang L, Zhang B, Liang BJ, Peng XH, Lin SX, Peng Y, Li XP. Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther 2013;14:1133-42. [PMID: 24025417 DOI: 10.4161/cbt.26170] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
66 Jamali L, Tofigh R, Tutunchi S, Panahi G, Borhani F, Akhavan S, Nourmohammadi P, Ghaderian SM, Rasouli M, Mirzaei H. Circulating microRNAs as diagnostic and therapeutic biomarkers in gastric and esophageal cancers. J Cell Physiol 2018;233:8538-50. [DOI: 10.1002/jcp.26850] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 20.8] [Reference Citation Analysis]
67 Wolfe AR, Bambhroliya A, Reddy JP, Debeb BG, Huo L, Larson R, Li L, Ueno NT, Woodward WA. MiR-33a Decreases High-Density Lipoprotein-Induced Radiation Sensitivity in Breast Cancer. Int J Radiat Oncol Biol Phys 2016;95:791-9. [PMID: 27055396 DOI: 10.1016/j.ijrobp.2016.01.025] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
68 Macharia LW, Wanjiru CM, Mureithi MW, Pereira CM, Ferrer VP, Moura-Neto V. MicroRNAs, Hypoxia and the Stem-Like State as Contributors to Cancer Aggressiveness. Front Genet. 2019;10:125. [PMID: 30842790 DOI: 10.3389/fgene.2019.00125] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
69 Denham J. Exercise and epigenetic inheritance of disease risk. Acta Physiol (Oxf) 2018;222. [PMID: 28371392 DOI: 10.1111/apha.12881] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
70 Yang Q, Yang F, Dai W, Meng X, Wei W, Cheng Y, Dong J, Lu H, Dong H. DNA Logic Circuits for Multiple Tumor Cells Identification Using Intracellular MicroRNA Molecular Bispecific Recognition. Adv Healthc Mater 2021;10:e2101130. [PMID: 34486246 DOI: 10.1002/adhm.202101130] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
71 Pezuk JA, Miller TLA, Bevilacqua JLB, de Barros ACSD, de Andrade FEM, E Macedo LFA, Aguilar V, Claro ANM, Camargo AA, Galante PAF, Reis LFL. Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography. Oncotarget 2017;8:83940-8. [PMID: 29137394 DOI: 10.18632/oncotarget.20806] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
72 Wang L, Chen X, Wang L, Wang S, Li W, Liu Y, Zhang J. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects. IUBMB Life 2021;73:1378-91. [PMID: 34559939 DOI: 10.1002/iub.2562] [Reference Citation Analysis]
73 Russano M, Napolitano A, Ribelli G, Iuliani M, Simonetti S, Citarella F, Pantano F, Dell'Aquila E, Anesi C, Silvestris N, Argentiero A, Solimando AG, Vincenzi B, Tonini G, Santini D. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. J Exp Clin Cancer Res 2020;39:95. [PMID: 32460897 DOI: 10.1186/s13046-020-01601-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
74 Powrózek T, Kuźnar-Kamińska B, Dziedzic M, Mlak R, Batura-Gabryel H, Sagan D, Krawczyk P, Milanowski J, Małecka-Massalska T. The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection. Pathol Res Pract 2017;213:1384-7. [PMID: 28964576 DOI: 10.1016/j.prp.2017.09.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
75 Piña-Sánchez P, Valdez-Salazar HA, Ruiz-Tachiquín ME. Circulating microRNAs and their role in the immune response in triple-negative breast cancer. Oncol Lett 2020;20:224. [PMID: 32968446 DOI: 10.3892/ol.2020.12087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
76 Zhou Y, Sun YC, Gao KW, Zhu L. Regulatory effect of miR-346/DKK3 axis on tumor cell proliferation in colon cancer. Shijie Huaren Xiaohua Zazhi 2018; 26(34): 1979-1988 [DOI: 10.11569/wcjd.v26.i34.1979] [Reference Citation Analysis]
77 Cheng T, Zhan X. Pattern recognition for predictive, preventive, and personalized medicine in cancer. EPMA J 2017;8:51-60. [PMID: 28620443 DOI: 10.1007/s13167-017-0083-9] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 11.4] [Reference Citation Analysis]
78 Gholamin S, Mirzaei H, Razavi S, Hassanian SM, Saadatpour L, Masoudifar A, Shahidsales S, Avan A. GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma. J Cell Physiol 2018;233:866-79. [DOI: 10.1002/jcp.25793] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
79 Vetrivel S, Zhang R, Engel M, Altieri B, Braun L, Osswald A, Bidlingmaier M, Fassnacht M, Beuschlein F, Reincke M, Chen A, Sbiera S, Riester A. Circulating microRNA Expression in Cushing's Syndrome. Front Endocrinol (Lausanne) 2021;12:620012. [PMID: 33692756 DOI: 10.3389/fendo.2021.620012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Abdouh M, Zhou S, Arena V, Arena M, Lazaris A, Onerheim R, Metrakos P, Arena GO. Transfer of malignant trait to immortalized human cells following exposure to human cancer serum. J Exp Clin Cancer Res. 2014;33:86. [PMID: 25266310 DOI: 10.1186/s13046-014-0086-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
81 Papadaki C, Monastirioti A, Rounis K, Makrakis D, Kalbakis K, Nikolaou C, Mavroudis D, Agelaki S. Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy. Cancers (Basel) 2020;12:E1282. [PMID: 32438598 DOI: 10.3390/cancers12051282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
82 Blanco-Calvo M, Calvo L, Figueroa A, Haz-Conde M, Antón-Aparicio L, Valladares-Ayerbes M. Circulating microRNAs: molecular microsensors in gastrointestinal cancer. Sensors (Basel) 2012;12:9349-62. [PMID: 23012546 DOI: 10.3390/s120709349] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
83 Shivapurkar N, Weiner LM, Marshall JL, Madhavan S, Deslattes Mays A, Juhl H, Wellstein A. Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One. 2014;9:e84686. [PMID: 24400111 DOI: 10.1371/journal.pone.0084686] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
84 Yi Z, Fu Y, Ji R, Li R, Guan Z. Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One 2012;7:e43184. [PMID: 22900099 DOI: 10.1371/journal.pone.0043184] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 7.1] [Reference Citation Analysis]
85 Kuhlmann JD, Chebouti I, Kimmig R, Buderath P, Reuter M, Puppel S, Wimberger P, Kasimir-bauer S. Extracellular vesicle-associated miRNAs in ovarian cancer – design of an integrated NGS-based workflow for the identification of blood-based biomarkers for platinum-resistance. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:1053-62. [DOI: 10.1515/cclm-2018-1048] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
86 Cao W, Zhou D, Tang W, An H, Zhang Y. Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation. PeerJ 2019;7:e7025. [PMID: 31249732 DOI: 10.7717/peerj.7025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
87 Liu WJ, Xu Q, Sun LP, Dong QG, He CY, Yuan Y. Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol. 2015;36:3337-3343. [PMID: 25549793 DOI: 10.1007/s13277-014-2967-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
88 Najafian A, Mathur A, Zeiger MA. Molecular Profiles and the “Indeterminate” Thyroid Nodule. In: Hanks JB, Inabnet Iii WB, editors. Controversies in Thyroid Surgery. Cham: Springer International Publishing; 2016. pp. 143-56. [DOI: 10.1007/978-3-319-20523-6_11] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
89 Cheng Q, Ma X, Cao H, Chen Z, Wan X, Chen R, Peng R, Huang J, Jiang B. Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells. Mol Med Rep 2017;15:597-604. [PMID: 28035389 DOI: 10.3892/mmr.2016.6078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
90 Chiodoni C, Di Martino MT, Zazzeroni F, Caraglia M, Donadelli M, Meschini S, Leonetti C, Scotlandi K. Cell communication and signaling: how to turn bad language into positive one. J Exp Clin Cancer Res 2019;38:128. [PMID: 30867009 DOI: 10.1186/s13046-019-1122-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
91 Zhou Y, Huang Z, Wu S, Zang X, Liu M, Shi J. miR-33a is up-regulated in chemoresistant osteosarcoma and promotes osteosarcoma cell resistance to cisplatin by down-regulating TWIST. J Exp Clin Cancer Res 2014;33:12. [PMID: 24468065 DOI: 10.1186/1756-9966-33-12] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 10.4] [Reference Citation Analysis]
92 Sun W, Li WJ, Wu CY, Zhong H, Wen WP. CD45RA-Foxp3high but not CD45RA+Foxp3low suppressive T regulatory cells increased in the peripheral circulation of patients with head and neck squamous cell carcinoma and correlated with tumor progression. J Exp Clin Cancer Res 2014;33:35. [PMID: 24761979 DOI: 10.1186/1756-9966-33-35] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
93 Allegra A, Ettari R, Innao V, Bitto A. Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma. Cells 2021;10:448. [PMID: 33672466 DOI: 10.3390/cells10020448] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Naser Al Deen N, Nassar F, Nasr R, Talhouk R. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability. In: Ahmad A, editor. Breast Cancer Metastasis and Drug Resistance. Cham: Springer International Publishing; 2019. pp. 335-64. [DOI: 10.1007/978-3-030-20301-6_18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
95 Dai TY, Cao L, Yang ZC, Li YS, Tan L, Ran XZ, Shi CM. P68 RNA helicase as a molecular target for cancer therapy. J Exp Clin Cancer Res 2014;33:64. [PMID: 25150365 DOI: 10.1186/s13046-014-0064-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
96 Li LZ, Wu ZZ, Lv Z. The Clinical Significance of miR-21 in Guiding Chemotherapy for Patients with Osteosarcoma. Pharmgenomics Pers Med 2021;14:1247-61. [PMID: 34616172 DOI: 10.2147/PGPM.S321637] [Reference Citation Analysis]
97 Qian Z, Shen Q, Yang X, Qiu Y, Zhang W. The Role of Extracellular Vesicles: An Epigenetic View of the Cancer Microenvironment. Biomed Res Int 2015;2015:649161. [PMID: 26582468 DOI: 10.1155/2015/649161] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
98 Pourteymourfard Tabrizi Z, Jami M. Selection of suitable bioinformatic tools in micro-RNA research. Gene Reports 2020;21:100893. [DOI: 10.1016/j.genrep.2020.100893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Gao X, Jin W. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett 2014;353:25-31. [PMID: 25042866 DOI: 10.1016/j.canlet.2014.07.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
100 Leuenberger N, Robinson N, Saugy M. Circulating miRNAs: a new generation of anti-doping biomarkers. Anal Bioanal Chem 2013;405:9617-23. [PMID: 24077830 DOI: 10.1007/s00216-013-7340-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
101 Decruyenaere P, Offner F, Vandesompele J. Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review. Exp Hematol Oncol 2021;10:13. [PMID: 33593440 DOI: 10.1186/s40164-021-00208-3] [Reference Citation Analysis]
102 Zhang P, Ouyang Y, Sohn YS, Nechushtai R, Pikarsky E, Fan C, Willner I. pH- and miRNA-Responsive DNA-Tetrahedra/Metal-Organic Framework Conjugates: Functional Sense-and-Treat Carriers. ACS Nano 2021;15:6645-57. [PMID: 33787219 DOI: 10.1021/acsnano.0c09996] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
103 Elovitz MA, Brown AG, Anton L, Gilstrop M, Heiser L, Bastek J. Distinct cervical microRNA profiles are present in women destined to have a preterm birth. Am J Obstet Gynecol 2014;210:221.e1-11. [PMID: 24565431 DOI: 10.1016/j.ajog.2013.12.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
104 Wang Z, Wang J, Yang Y, Hao B, Wang R, Li Y, Wu Q. Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer. J Exp Clin Cancer Res 2013;32:76. [PMID: 24422944 DOI: 10.1186/1756-9966-32-76] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
105 Jurj A, Pasca S, Teodorescu P, Tomuleasa C, Berindan-Neagoe I. Basic knowledge on BCR-ABL1-positive extracellular vesicles. Biomark Med 2020;14:451-8. [PMID: 32270699 DOI: 10.2217/bmm-2019-0510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
106 Shukla V, Varghese VK, Kabekkodu SP, Mallya S, Chakrabarty S, Jayaram P, Pandey D, Banerjee S, Sharan K, Satyamoorthy K. Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer. Gynecol Oncol 2019;155:135-43. [PMID: 31434614 DOI: 10.1016/j.ygyno.2019.08.012] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
107 Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, Zengin G, Babes EE, Brisc C, Stoicescu M, Toma MM, Sava C, Bungau SG. Bioinformatics Accelerates the Major Tetrad: A Real Boost for the Pharmaceutical Industry. Int J Mol Sci 2021;22:6184. [PMID: 34201152 DOI: 10.3390/ijms22126184] [Reference Citation Analysis]
108 Fatima A, Morris DG. MicroRNAs in domestic livestock. Physiological Genomics 2013;45:685-96. [DOI: 10.1152/physiolgenomics.00009.2013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
109 Wang Z, Lv J, Zou X, Huang Z, Zhang H, Liu Q, Jiang L, Zhou X, Zhu W. A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients. Gene 2019;693:37-45. [PMID: 30684524 DOI: 10.1016/j.gene.2019.01.016] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
110 Aushev VN, Zborovskaya IB, Laktionov KK, Girard N, Cros MP, Herceg Z, Krutovskikh V. Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. PLoS One. 2013;8:e78649. [PMID: 24130905 DOI: 10.1371/journal.pone.0078649] [Cited by in Crossref: 85] [Cited by in F6Publishing: 84] [Article Influence: 9.4] [Reference Citation Analysis]
111 Malczewska A, Kidd M, Matar S, Kos-Kudla B, Modlin IM. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors. Neuroendocrinology. 2018;107:73-90. [PMID: 29566385 DOI: 10.1159/000487326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
112 Riquelme I, Letelier P, Riffo-Campos AL, Brebi P, Roa JC. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer. Int J Mol Sci. 2016;17:424. [PMID: 27011182 DOI: 10.3390/ijms17030424] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
113 Chiam K, Mayne GC, Wang T, Watson DI, Irvine TS, Bright T, Smith LT, Ball IA, Bowen JM, Keefe DM, Thompson SK, Hussey DJ. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus. World J Gastroenterol 2020; 26(20): 2570-2583 [PMID: 32523312 DOI: 10.3748/wjg.v26.i20.2570] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
114 Cellini F, Morganti AG, Genovesi D, Silvestris N, Valentini V. Role of microRNA in response to ionizing radiations: evidences and potential impact on clinical practice for radiotherapy. Molecules 2014;19:5379-401. [PMID: 24879584 DOI: 10.3390/molecules19045379] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
115 Zhang L, Chen H, He F, Zhang S, Li A, Zhang A, Zhang A. MicroRNA-320a Promotes Epithelial Ovarian Cancer Cell Proliferation and Invasion by Targeting RASSF8. Front Oncol 2021;11:581932. [PMID: 33718138 DOI: 10.3389/fonc.2021.581932] [Reference Citation Analysis]
116 Ragusa M, Barbagallo C, Brex D, Caponnetto A, Cirnigliaro M, Battaglia R, Barbagallo D, Di Pietro C, Purrello M. Molecular Crosstalking among Noncoding RNAs: A New Network Layer of Genome Regulation in Cancer. Int J Genomics 2017;2017:4723193. [PMID: 29147648 DOI: 10.1155/2017/4723193] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
117 Gandhi R, Healy B, Gholipour T, Egorova S, Musallam A, Hussain MS, Nejad P, Patel B, Hei H, Khoury S, Quintana F, Kivisakk P, Chitnis T, Weiner HL. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol 2013;73:729-40. [PMID: 23494648 DOI: 10.1002/ana.23880] [Cited by in Crossref: 162] [Cited by in F6Publishing: 154] [Article Influence: 18.0] [Reference Citation Analysis]
118 Fanale D, Amodeo V, Bazan V, Insalaco L, Incorvaia L, Barraco N, Castiglia M, Rizzo S, Santini D, Giordano A, Castorina S, Russo A. Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? Oncotarget 2016;7:29321-32. [PMID: 27081088 DOI: 10.18632/oncotarget.8722] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
119 Sartorius K, Makarova J, Sartorius B, An P, Winkler C, Chuturgoon A, Kramvis A. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis. Cells 2019;8:E1504. [PMID: 31771261 DOI: 10.3390/cells8121504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
120 Kuhlmann JD, Baraniskin A, Hahn SA, Mosel F, Bredemeier M, Wimberger P, Kimmig R, Kasimir-Bauer S. Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancer. Clin Chem. 2014;60:206-213. [PMID: 24212085 DOI: 10.1373/clinchem.2013.213066] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
121 Falcon-perez JM, Royo F. Circulating RNA: looking at the liver through a frosted glass. Biomarkers 2015;20:339-54. [DOI: 10.3109/1354750x.2015.1101785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Ragusa M, Barbagallo C, Cirnigliaro M, Battaglia R, Brex D, Caponnetto A, Barbagallo D, Di Pietro C, Purrello M. Asymmetric RNA Distribution among Cells and Their Secreted Exosomes: Biomedical Meaning and Considerations on Diagnostic Applications. Front Mol Biosci 2017;4:66. [PMID: 29046875 DOI: 10.3389/fmolb.2017.00066] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]